Accordingly, a gene signature using all differentially expressed genes identified in the mutant organoid models, was able to clearly separate the primary FLC tumor samples into 3 clusters: the BAP1-FLC tumors, the fusion-FLC tumors and the normal livers (Supplementary Fig. 5d). This evidence concerns the gene BAP1 and neoplasm.